Alzheimer's drug market to hit $5.5 billion by 2009, study says
Toronto-based Millennium Research Group predicts the Alzheimer's disease drug market in the United States, Europe and Japan will grow by 15 percent annually for the next five years – which could benefit Wisconsin biotechs....